Immunotherapy for Mesothelioma: Current Status and Future Directions
September 11, 2018 | Online

Overview

This webinar will cover the history and current status of immunotherapy for treating mesothelioma, and the most pressing unanswered questions in this setting. It will include a bench to bedside review of chemo-immunotherapy in mesothelioma and the potential future of this field.

Activity Objectives:

In this one-hour webinar, Professor Nowak will:

  • review the current state-of-the-art for treatment of malignant pleural mesothelioma;
  • examine the emerging role of immunotherapy for mesothelioma;
  • provide updated results of recently completed studies evaluating new agents and new approaches to the management of malignant mesothelioma; and
  • identify the major, ongoing and planned clinical trials most likely to impact patient care in the near future.

What you should expect to learn

  • Identify and discuss recent data and current clinical research evaluating the efficacy and safety of immunotherapeutic agents in the treatment of malignant mesothelioma (“MM”).
  • Assess those clinical research findings that are most relevant to treating clinicians.
  • Appraise the utility of immunotherapy in the management of MM and its evolutionary role in current treatment algorithms.

Contact